Organigram Global Inc. (TSX:OGI)

Market Cap	193.18M -46.5%
Revenue (ttm)	309.18M +38.1%
Net Income	86.62M +1,014.5%
EPS	0.64 +821.8%
Shares Out	141.01M
PE Ratio	2.16
Forward PE	17.13
Dividend	n/a
Ex-Dividend Date	n/a

Volume	22,075
Open	1.380
Previous Close	1.370
Day's Range	1.350 - 1.380
52-Week Range	1.195 - 3.090
Beta	1.91
Analysts	Buy
Price Target	3.12 (+127.74%)
Est. Earnings	Dec 15, 2026

About Organigram Global

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2010
• Employees: 1,120
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: OGI

Financial Performance

In fiscal year 2025, Organigram Global's revenue was 259.18 million, an increase of 62.15% compared to the previous year's 159.84 million. Losses were -24.76 million, -45.51% less than in 2024.

Analyst Summary

According to 5 analysts, the average rating for OGI stock is "Buy." The 12-month stock price target is $3.12, which is an increase of 127.74% from the latest price.

Price Target

$3.12

(127.74% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Oct 9, 2026

Data Sources Report a data error